Atlas Venture Opportunity Fund II, L.P.'s Net Worth
$10.7 Million
Who is Atlas Venture Opportunity Fund II, L.P.?
Atlas Venture Opportunity Fund II, L.P. has an estimated net worth of $10.7 Million. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., Disc Medicine, Inc., Dyne Therapeutics, Inc., and Korro Bio, Inc..
SEC CIK
Atlas Venture Opportunity Fund II, L.P.'s CIK is 0001885327
Past Insider Trading and Trends
2022 was Atlas Venture Opportunity Fund II, L.P.'s most active year for acquiring shares with 2 total transactions. Atlas Venture Opportunity Fund II, L.P.'s most active month to acquire stocks was the month of May. 2022 saw Atlas Venture Opportunity Fund II, L.P. paying a total of $21,500,021.70 for 1,701,248 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $15.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 766.67K |
$15.00 | $11,500,005.00 | 766.67K |
Jun 17
| |||
| No matching records found | |||||||||
Dyne Therapeutics, Inc. (DYN) Snapshot price: $21.49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.98% | -46.53K |
$30.05 | -$1,398,346.70 | 2.31M |
Scheduled
|
Mar 1
| ||
Form 4
| -5.89% | -807.84K |
$24.32 | -$19,626,902.97 | 12.9M |
Scheduled
|
Feb 26 - Feb 28
| ||
Form 4
| -5.35% | -500.79K |
$22.68 | -$11,339,780.44 | 8.86M |
Scheduled
|
Feb 21 - Feb 23
| ||
Form 4
|
∞
| 934.58K |
$10.70 | $10,000,016.70 | 934.58K |
Dec 12
| |||
| No matching records found | |||||||||
Korro Bio, Inc. (KRRO) Snapshot price: $59.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.08% | 17.86K |
$56.00 | $999,992.00 | 195.07K |
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Disc Medicine, Inc. (IRON) Snapshot price: $65.685
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.11% | -150.00K |
$67.65 | -$10,147,500.00 | 2.3M |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Homology Medicines, Inc. (FIXX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||